{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:17:06Z","timestamp":1766747826122,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014435","name":"Austrian Federal Ministry of Economy, Family and Youth","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ajo.2014.04.028","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T00:18:02Z","timestamp":1398989882000},"page":"328-336.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of Vitreomacular Adhesion on Ranibizumab Mono- and Combination Therapy for Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"158","author":[{"given":"Sebastian M.","family":"Waldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Simader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Mayr-Sponer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Schmidt-Erfurth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9827","key":"10.1016\/j.ajo.2014.04.028_bib1","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","article-title":"Age-related macular degeneration","volume":"379","author":"Lim","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ajo.2014.04.028_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration","volume":"26","author":"Ferrara","year":"2006","journal-title":"Retina"},{"issue":"14","key":"10.1016\/j.ajo.2014.04.028_bib3","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.ajo.2014.04.028_bib4","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2014.04.028_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ajo.2007.01.028","article-title":"An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration","volume":"143","author":"Fung","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"20","key":"10.1016\/j.ajo.2014.04.028_bib6","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajo.2014.04.028_bib7","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.ophtha.2012.03.053","article-title":"Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results","volume":"119","author":"Martin","year":"2012","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2014.04.028_bib8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ophtha.2012.04.015","article-title":"Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial","volume":"119","author":"Chakravarthy","year":"2012","journal-title":"Ophthalmology"},{"issue":"9900","key":"10.1016\/j.ajo.2014.04.028_bib9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0140-6736(13)61501-9","article-title":"Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial","volume":"382","author":"Chakravarthy","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajo.2014.04.028_bib10","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/IAE.0b013e31827b6324","article-title":"Changes in visual acuity in patients with wet age-related macular degeneration treated with intravitreal ranibizumab in daily clinical practice: the LUMIERE study","volume":"33","author":"Cohen","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2014.04.028_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2013.12.029","article-title":"Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration","author":"Simader","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2014.04.028_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/IAE.0b013e31828991d6","article-title":"Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion: a systematic review and metaanalysis","volume":"33","author":"Jackson","year":"2013","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajo.2014.04.028_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ophtha.2010.04.015","article-title":"Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration","volume":"118","author":"Lee","year":"2011","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2014.04.028_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/IAE.0b013e318295f72e","article-title":"Role of posterior vitreous detachment on outcome of anti-vascular endothelial growth factor treatment in age-related macular degeneration","volume":"34","author":"Uney","year":"2014","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajo.2014.04.028_bib15","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1016\/j.ophtha.2013.07.042","article-title":"The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole","volume":"120","author":"Duker","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2014.04.028_bib16","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ophtha.2013.11.030","article-title":"The premacular bursa's shape revealed in\u00a0vivo by swept-source optical coherence tomography","volume":"121","author":"Schaal","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2014.04.028_bib17","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0161-6420(94)31140-7","article-title":"Vitreomacular observations. I. Vitreomacular adhesion and hole in the premacular hyaloid","volume":"101","author":"Kakehashi","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2014.04.028_bib18","first-page":"1","article-title":"Posterior vitreous detachment following intravitreal drug injection","author":"Geck","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2014.04.028_bib19","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","article-title":"Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes","volume":"367","author":"Stalmans","year":"2012","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ajo.2014.04.028_bib20","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/IAE.0b013e3182845d18","article-title":"Visual and anatomical outcomes of anti-vascular endothelial growth factor therapy in exudative age-related macular degeneration and vitreomacular interface disease: vitreomacular adhesion and epiretinal membrane","volume":"33","author":"Green-Simms","year":"2013","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.ajo.2014.04.028_bib21","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/j.ophtha.2013.05.032","article-title":"Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration","volume":"120","author":"Mayr-Sponer","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2014.04.028_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0002-9394(01)00967-9","volume":"131","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2014.04.028_bib23","first-page":"198","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials\u2014TAP Report 2","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2014.04.028_bib24","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.ophtha.2005.09.007","article-title":"Time course and morphology of vascular effects associated with photodynamic therapy","volume":"112","author":"Schmidt-Erfurth","year":"2005","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2014.04.028_bib25","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1167\/iovs.02-1115","article-title":"Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium\u2013derived factor","volume":"44","author":"Schmidt-Erfurth","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.ajo.2014.04.028_bib26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00417-010-1307-z","article-title":"Verteporfin PDT for non-standard indications\u2014a review of current literature","volume":"248","author":"Chan","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2014.04.028_bib27","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ophtha.2012.02.002","article-title":"Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results","volume":"119","author":"Larsen","year":"2012","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2014.04.028_bib28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.ophtha.2012.02.003","article-title":"Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month results of the DENALI Study","volume":"119","author":"Kaiser","year":"2012","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2014.04.028_bib29","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST Study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"issue":"10","key":"10.1016\/j.ajo.2014.04.028_bib30","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.ophtha.2013.03.016","article-title":"Combination therapy for neovascular age-related macular degeneration refractory to anti\u2013vascular endothelial growth factor agents","volume":"120","author":"Tozer","year":"2013","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2014.04.028_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ajo.2007.07.024","article-title":"Posterior vitreomacular adhesion: a potential risk factor for exudative age-related macular degeneration?","volume":"144","author":"Krebs","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2014.04.028_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2009.01.014","article-title":"Vitreomacular adhesion in active and end-stage age-related macular degeneration","volume":"148","author":"Robison","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2014.04.028_bib33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ajo.2008.04.027","article-title":"The role of abnormal vitreomacular adhesion in age-related macular degeneration: spectral optical coherence tomography and surgical results","volume":"146","author":"Mojana","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2014.04.028_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ajo.2008.10.003","article-title":"Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study","volume":"147","author":"Lee","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2014.04.028_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/IAE.0b013e3182278b80","article-title":"Influence of vitreomacular adhesion on the development of exudative age-related macular degeneration: 4-year results of a longitudinal study","volume":"32","author":"Waldstein","year":"2012","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajo.2014.04.028_bib36","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0161-6420(03)00452-4","article-title":"Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin","volume":"110","author":"Schmidt-Erfurth","year":"2003","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2014.04.028_bib37","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/jamaophthalmol.2013.4578","article-title":"Evolution of vitreomacular detachment in healthy subjects","volume":"131","author":"Itakura","year":"2013","journal-title":"JAMA Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414002311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939414002311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:11:10Z","timestamp":1757596270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939414002311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0002939414002311"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2014.04.028","relation":{},"ISSN":["0002-9394"],"issn-type":[{"type":"print","value":"0002-9394"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Vitreomacular Adhesion on Ranibizumab Mono- and Combination Therapy for Neovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2014.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}